ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 876–883
DOI: 10.46882/AJIDR/149027
Article Type: Research Article
Title: Prevalence, genotype diversity, and albendazole-ivermectin efficacy against Strongyloides stercoralis hyperinfection risk in immunosuppressed adults
Names of Authors: Valentina Castaneda¹*, Babatunde Adeyinka², Joon-Young Park³
Abstract: Strongyloides stercoralis causes chronic autoinfective intestinal helminthiasis that can progress to fatal disseminated hyperinfection during corticosteroid or immunosuppressive therapy. We compared agar plate culture, serology, and real-time polymerase chain reaction screening prior to immunosuppressive treatment initiation. Stool and serum samples from 310 oncology and rheumatology patients were examined at baseline and day 28 post-ivermectin therapy. Strongyloides stercoralis infection was detected in 13.9 percent of patients, achieving a 95.3 percent parasitological cure rate following two-dose oral ivermectin. Routine pre-immunosuppression screening prevents catastrophic hyperinfection syndromes.
Keywords: Strongyloides stercoralis, Strongyloidiasis, Ivermectin efficacy, Immunosuppression, Neglected tropical diseases
Citation: Castaneda V, Adeyinka B, Park J (2026). Prevalence, genotype diversity, and albendazole-ivermectin efficacy against Strongyloides stercoralis hyperinfection risk in immunosuppressed adults. African Journal of Infectious Diseases Research, 13(11): 876–883. DOI: 10.46882/AJIDR/149027
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read